23 May 2013
Keywords: sb, wins, positive, opinion, avandia, europe, use
Article | 23 March 2000
Following an appeal, SmithKline Beecham has won a positiverecommendation to market its antidiabetic drug Avandia (rosiglitazone)
from the European Medicines ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2000
3 April 2000
31 March 2000
© 2013 thepharmaletter.com